Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

Solid Media Used to Isolate Leptospira

By Labmedica International staff writers
Posted on 25 Feb 2013
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Isolation of Leptospira, from clinical samples and testing of antimicrobial susceptibility are difficult and time-consuming.

Pathogenic Leptospira are slow-growing Gram-negative spirochetes and a new solid medium that facilitates more-rapid growth of these organisms has been developed

Microbiologists at the Mahidol University (Bangkok, Thailand) developed the new solid medium, called LVW agar, by testing the effects of combinations of ingredients and incubation conditions. All recipes contained three core ingredients and a variable concentration of two additional ingredients. A total of 109 pathogenic Leptospira isolates were used during the development and evaluation of the new solid medium and Etest, which is well-established method for antimicrobial resistance testing, antibiotic susceptibility testing in microbiology laboratories around the world.

The medium was developed by evaluating the effects of numerous factors on the growth rate of a strain of Leptospira interrogans. These included the type of base agar, the concentration of rabbit serum (RS), and the concentration and duration of carbon dioxide (CO2) incubation during the initial period of culture. The highest growth rate of this strain was achieved using a Noble agar base supplemented with 10% RS and named LVW agar, with an initial incubation at 30 °C in 5% CO2 for two days prior to continuous culture in air at 30 °C.

These conditions were used to develop the Etest for three species, L. interrogans, L. kirschnerii, and L. borgpetersenii. The minimum inhibitory concentrations (MICs) were read on day seven for all samples. The validated Etest methodology was performed for 109 Leptospira isolates with five antimicrobial drugs, penicillin G, doxycycline, ceftriaxone, cefotaxime, and chloramphenicol. The MIC90 values were as follows: penicillin G, 0.064 units/mL; doxycycline, 0.19 µg/mL; cefotaxime, 0.047 µg/mL; ceftriaxone, 0.5 µg/mL; and chloramphenicol, 2 µg/mL.

Leptospirosis is a zoonotic disease that has a worldwide distribution but has the greatest impact on health in developing countries, where it is often grossly under recognized. The authors concluded that LVW agar that enables rapid growth, isolation of single colonies, and simple antimicrobial susceptibility testing for Leptospira species will become widely used in diagnostic microbiology laboratories, but especially in resource-limited settings. The study was published in the January 2013 issue of the journal Antimicrobial Agents and Chemotherapy.

Related Links:

Mahidol University




KARL HECHT GMBH & CO KG
CELLAVISION AB
MEDLAB Asia
PERIPHERAL VISIONS INC

Channels

Genetic Tests

view channel
Image: Histopathology of tuberculoid leprosy in a skin section (Photo courtesy Dr. D.S. Ridley, Wellcome Images).

Genes Discovered Influence Risk of Developing Leprosy

Leprosy, a chronic dermatological and neurological disease, is caused by infection with Mycobacterium leprae, and its manifestation, progression and prognosis are strongly associated with the proficiency... Read more

Hematology

view channel
Image: Plastic bag containing 0.5 to 0.7 liters of packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution (Photo courtesy of Fresenius HemoCare).

Transfusion Protocols Compared After Cardiac Surgery

Unnecessary blood transfusions may increase healthcare costs both directly, because blood is an increasingly scarce and expensive resource, and indirectly due to the complications associated with transfusion.... Read more

Industry News

view channel

Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads

The Latin American in vitro diagnostics (IVD) sector was estimated at USD 2.4 billion in 2014. Population growth, government insurance, newly insured patients, and updated healthcare facilities have driven growth in the region and will continue to propel demand, according to Kalorama Information (New York, NY, USA).... Read more
 

Events

06 Apr 2015 - 08 Apr 2015
07 Apr 2015 - 09 Apr 2015
13 Apr 2015 - 16 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.